CD138 as a Specific CSF Biomarker of Multiple Sclerosis

Abstract

This study provides Class II evidence that CD138 distinguishes multiple sclerosis from other inflammatory neurologic disorders with an AUC of 0.85 (95% CI 0.75-0.95).